Tariff wars to hit popular US-made drugs in China, regulator data shows
- Quantung Pharmaceutical Export company
- Apr 15
- 1 min read
Updated: Apr 15
People visit the booth of drugmaker Sanofi at the China International Import Expo (CIIE) in Shanghai, China November 7, 2024. REUTERS/Andrew Silver/File Photo Purchase Licensing Rights
SHANGHAI, April 15 (Reuters) - Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, a Reuters review of Chinese regulator data showed, and threaten to add to drugmakers' costs.
China announced on Friday that it would raise its levies on imports of U.S. goods to 125%, hitting back at U.S. President Donald Trump's decision to single out the world's second-largest economy for higher duties.
Comments